Engrafted glial progenitor cells yield long-term integration and sensory improvement in aged mice
A 2025 systematic review of 80 randomized clinical trials of patients taking GLP-1 RAs, published in the Journal of the American Medical Associations JAMA Psychiatry, found that GLP-1 RA treatment in patients with obesity and/or diabetes was not associated with an increased risk of depressive symptoms
"Pregnancy or intention to become pregnant were exclusion criteria in our trials with semaglutide in both obesity and type 2 diabetes
PlexusDx offers semaglutide, tirzepatide, oral and injectable options, and combination products, allowing your clinician to find the best fit for your side effect profile
Semaglutidea glucagon-like peptide-1 (GLP-1) receptor agonisthas demonstrated an average weight loss of 15-17% over 68 weeks in clinical trials, regardless of whether the medication comes from a brand-name manufacturer or a licensed compounding pharmacy
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
.jpg?ver=1781082226)
